Business ❯Healthcare ❯Drug Development

Clinical Trials

Eli Lilly Xevinapant

Novo Nordisk Faces Investor Concerns as Wegovy Sales Stagnate and Competition Intensifies

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Eli Lilly Lowers 2024 Revenue Forecast as Weight-Loss Drug Sales Lag